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Objectives: To identify important pathogen recognition receptor (PRR) pathways regulating innate im-
mune responses and outcome in Staphylococcus aureus sepsis.
Methods: We analysed whether candidate PRR pathway genetic variants were associated with killed
S. aureuseinduced cytokine responses ex vivo and performed follow-up in vitro studies. We tested the
association of our top-ranked variant with cytokine responses and clinical outcomes in a prospective
multicentre cohort of patients with staphylococcal sepsis.
Results: An intronic TLR4 polymorphism and expression quantitative trait locus, rs1927907, was highly
associated with cytokine release induced by stimulation of blood from healthy Thai subjects with
S. aureus ex vivo. S. aureus did not induce TLR4-dependent NF-kB activation in transfected HEK293 cells.
In monocytes, tumor necrosis factor (TNF)-a release induced by S. aureuswas not blunted by a TLR4/MD-
2 neutralizing antibody, but in a monocyte cell line, TNF-a was reduced by knockdown of TLR4. In Thai
patients with staphylococcal sepsis, rs1927907 was associated with higher interleukin (IL)-6 and IL-8
levels as well as with respiratory failure. S. aureuseinduced responses in blood were most highly
correlated with responses to Gram-negative stimulants whole blood.t of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok
ratita).
Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under
g/licenses/by-nc-nd/4.0/).
N. Chantratita et al. / Clinical Microbiology and Infection 23 (2017) 47.e1e47.e1047.e2Conclusions: A genetic variant in TLR4 is associated with cytokine responses to S. aureus ex vivo and
plasma cytokine levels and respiratory failure in staphylococcal sepsis. While S. aureus does not express
lipopolysaccharide or activate TLR4 directly, the innate immune response to S. aureus does appear to be
modulated by TLR4 and shares signiﬁcant commonality with that induced by Gram-negative pathogens
and lipopolysaccharide. N. Chantratita, CMI 2017;23:47.e1e47.e10
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The incidence of Gram-positive sepsis has been continually
increasing in recent years and is the predominant type of sepsis in
the United States [1]. Staphylococcus aureus is the most common
Gram-positive organism implicated in severe sepsis, with a mor-
tality rate of 30% [2]. Infectionwith S. aureus can be acquired in both
community and healthcare settings, and methicillin resistance in
both arenas is a major ongoing concern. A better understanding of
the hostepathogen interaction that may lead to novel approaches to
treating Gram-positive sepsis is therefore of paramount importance.
Pattern recognition receptors (PRRs) on host immune cells
mediate much of the inﬂammatory response to infection upon
activation by conserved pathogen-associated molecular patterns
(PAMPs) [3]. The PAMP-PRR interaction is a central driver of the
host response in sepsis, and a better comprehension of the PAMP-
PRR axis in human sepsis may unveil new targets for therapeutic
exploitation. As a Gram-positive organism, S. aureus cell wall
components activate membrane-bound PRRs such as Toll-like-
receptor (TLR) 2 (as a heterodimer with TLR1 or TLR6) and cyto-
plasmic NOD-like receptors [4]. Many of these PRRs are also
activated by PAMPs of Gram-negative organisms [3]. Lipopoly-
saccharide (LPS) has long been considered to be an essential
precipitant of the host inﬂammatory response to Gram-negative
infection, however [5]. In contrast to Gram-negative organisms,
S. aureus does not express LPS. Although various PRRs may be
activated by different bacteria, downstream signaling pathways
may converge or be interrelated [3]. It remains unclear whether
and how the fundamental inﬂammatory pathways activated in
Gram-positive and Gram-negative sepsis differ from one another
and drive outcome [6].
Innate immune genetic variation modulates the host response
to infection [7]. We hypothesized that key PRR genes regulating
inﬂammatory responses to S. aureus sepsis could be identiﬁed by
identifying human genetic variation associated with cytokine pro-
duction and clinical outcome. To test this hypothesis, we assessed
the relationship between ex vivo blood cytokine responses to
S. aureus and PRR pathway genetic variation in a large cohort of
healthy individuals, then validated our ﬁndings in a prospective
multicentre cohort of patients with staphylococcal sepsis.Methods
Ex vivo blood stimulation assays
Three hundred healthy Thai subjects donating blood at the blood
donation centre at Sunpasitthiprasong Hospital, Ubon Ratchathani,
Thailand, were recruited for a blood sample as previously reported
[8]. Those who met enrollment criteria gave written informed
consent to participate and provided a postdonation blood sample in
citrate tubes. A batch of 96-well immunoassay plates was generated
by adding 20 mL of stimuli in appropriate concentrations to eachwell. Plates were frozen at 80C until the day of use, when they
were thawed to 37C. Fresh whole blood (380 mL) anticoagulated
with citrate andmixed 1:1 with RPMI media was added to each well
[8]. Final concentrations of stimuli were as follows: whole heat-
killed S. aureus strain Newman 2.5  107 CFU/mL and
5.0  107 CFU/mL, whole heat-killed Burkholderia pseudomallei
K96243 2.5  107 CFU/mL, Salmonella typhimurium ﬂagellin 500 ng/
mL, Pam3CSK4 100 ng/mL (InvivoGen, San Diego, CA, USA),
Pam2CSK4 100 ng/mL (InvivoGen), MDP (10-muramyl dipeptide)
10 mg/mL (InvivoGen), TriDAP 10 mg/mL (InvivoGen), Escherichia coli
O111:B4 LPS 10 ng/mL (List Biological Laboratories, Campbell, CA,
USA) and Salmonella minnesota Re595 LPS 10 ng/mL (List Biological
Laboratories). Plates were placed on a shaker at 37C under 5% CO2
for 6 hours before being spun down; the plasma supernatant was
removed and frozen at 80C. Monocyte counts were performed in
the hospital clinical laboratory.Staphylococcal sepsis study
A prospective observational study of community onset S. aureus
sepsis was conducted at four hospitals in northeast Thailand be-
tween March 2010 and December 2013 [9]. Study sites were Sun-
pasitthiprasong Hospital, Ubon Ratchathani; Udon Thani Hospital,
Udon Thani; Srinagarind Hospital, Khon Kaen; and Khon Kaen
Hospital, Khon Kaen. Potential study patients were identiﬁed by
daily screening at each hospital diagnostic microbiology laboratory
for clinical samples taken from sterile sites that grew a pure growth
of S. aureus. Subsequent genetic analysis of isolates revealed that a
minority subset (19%) were S. argenteus [9], a recently described
closely related Staphylococcus species that is indistinguishable from
S. aureus in the diagnostic laboratory.Written informed consent was
obtained from all patients or their designee. Inclusion criteria were
as follows: age at least 14 years (who are admitted to the adult
wards), positive culture takenwithin 2 days of hospital admission or
after 2 days when sampling from a patient admitted with suspected
infection was delayed and at least two of four systemic inﬂamma-
tory response criteria met within 48 hours of culture. These criteria
were as follows: temperature <36C or >38C, heart rate >90 beats
per minute, respiratory rate >20 breaths per minute or PaCO2
<32 mm Hg or requiring mechanical ventilation, white blood cell
count <4000 or >12 000 cells/mL or >10% band forms. Baseline
clinical information was obtained from the medical records. Blood
was drawn at the time of enrollment, and plasmawas separated and
frozen at 80C. Patients were followed until hospital discharge,
and mortality was ascertained on the 28th day. Respiratory failure
was deﬁned as requirement for mechanical ventilation; shock was
deﬁned as requirement for vasopressors or inotropes.LPS and TLR4-stimulation assays
The presence of LPS in the heat-killed S. aureus strain Newman
preparation was determined by Limulus Amebocyte Lysate gel-clot
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to the manufacturer's instructions (sensitivity 0.03 EU/mL). TLR4-
dependent NF-kB activation by S. aureus was assessed by stimula-
tion of hTLR4/hMD-2/hCD14-transfected HEK293 cells, using a
modiﬁed version of a previous approach [10]. Cells were cultured in
a 96-well ﬂat-bottomed tissue culture plate at 35 000 cells per well
in Dulbecco modiﬁed Eagle medium (DMEM) plus 10% fetal bovine
serum and 1% L-glutamine. The following day, cells were transiently
transfected with 100 mL of transfection mixture comprising plas-
mids, transfection reagent (Polyfect; Qiagen, Valencia, CA, USA) and
DMEM. DNA was added in the following amounts per well: ELAM
(ﬁreﬂy luciferase) (50 ng), pRL-TK (Renilla luciferase) (5 ng), hTLR4
or empty vector (10 ng), hCD14 (1 ng) and hMD2 (1 ng). After
48 hours of incubation, transfected cells were stimulatedwith heat-
killed S. aureus or E. coli O111:B4 LPS (List Biological Laboratories,
Campbell, CA, USA) as a positive control. After 4 hours, cells were
washed with phosphate-buffered saline and lysed with passive
lysis buffer (Promega, Madison, WI, USA), and NF-kB activationwas
determined in 10 mL of lysate by the ratio of ﬁreﬂy to Renilla
luciferase light emission by the use of the Dual-Luciferase reporter
system (Promega).
Primary monocyte/monocyte cell line stimulations and TLR4
knockdown
Peripheral blood mononuclear cells were isolated from blood
obtained from fasting subjects who avoided recent strenuous ex-
ercise drawn into 8 mL Vacutainer CPT tubes (Becton Dickinson
(BD), San Diego, CA, USA). Subjects were between 18 and 65 years of
age, weighed between 100 and 350 pounds, were of Southeast
Asian ancestry, had no chronic medical conditions, were not
pregnant and had not delivered a child in the last 9 months, were
nonsmokers, took no medications other than oral contraceptives
and had no recent illness or vaccinations. Peripheral blood mono-
nuclear cells were further processed to monocytes using the
Monocyte Isolation Kit II (Miltenyi Biotec, San Diego, CA, USA).
Monocytes were plated in a 96-well plate at 50 000 cells per well
and rested overnight in complete RPMI media (10% fetal bovine
serum, 1% L-glutamine). The next day, cells were treated with a
monoclonal TLR4/MD-2 neutralizing antibody (mab-htlr4md2,
InvivoGen) or control isotype antibody (mabg1-ctrlm, InvivoGen)
at 20 mg/mL, 1 hour before addition of stimulus. Cells were stimu-
lated for 6 hours with LPS from B. pseudomallei K92643 at a ﬁnal
concentration of 1 ng/mL or heat-killed S. aureus at a bacteria to cell
ratio of 100 before supernatants were collected. THP-1-Dual cells
(InvivoGen), derived from the human THP-1 monocyte cell line,
were differentiated over a period of 72 hours with vitamin D3 (ﬁnal
concentration 10 pM/mL) and plated at 50 000 cells per well in
media containing D3. The next day, cells were transfected with
Silencer Select siRNA (Ambion, Austin, TX, USA) against TLR4
(#4392420) or Silencer Select Negative Control No. 1 siRNA
(#4390843) at a ﬁnal concentration of 5 nM using Lipofectamine
RNAiMAX Transfection Reagent (Life Technologies, Carlsbad, CA,
USA). To evaluate efﬁciency of gene knockdown, total RNA was
extracted from transfected cells after 48 hours using RNA lysis
buffer (Promega). Extracted RNA was converted into cDNA using
iScript Reverse Transcription Supermix (Bio-Rad, Hercules, CA,
USA), according to the manufacturer's protocol. Expression of TLR4
and UBC (housekeeping gene) was quantiﬁed by quantitative real-
time PCR using the SsoAdvanced Universal SYBRGreen Supermix
(Bio-Rad) run on a Chromo4 (Bio-Rad). Each reaction was run in
triplicate using 20 ng of template in a total volume of 20 mL. Re-
actions were incubated at 95C for 3 minutes, followed by 40 cycles
of 95C for 15 seconds and 60C for 30 seconds. PrimePCR primers
purchased from Bio-Rad for TLR4, Human (qHsaCED0037607) andUBC, Human (qHsaCED0023867) were used in the reactions. THP-
1-Dual cells were stimulated 48 hours after siRNA transfectionwith
either B. pseudomallei LPS 100 ng/mL as a positive control or heat-
killed S. aureus at a bacteria-to-cell ratio of 100 at 37C overnight.
The following day, supernatants were collected.
Genotyping and single nucleotide polymorphism (SNP) selection
DNA was extracted from whole blood of healthy subjects and
patients using theQIAampDNABloodMidi Kit (Qiagen). Selection of
ninety six nonsynonymous coding SNPs in PRR pathway genes was
performed by searching the HapMap project database (http://
hapmap.ncbi.nlm.nih.gov) and based on functional prediction us-
ing a FastSNP analysis (http://fastsnp.ibms.sinica.edu.tw) [11]. Tag
SNPs were selected from the Han Chinese in Beijing and Japanese in
Tokyo populations in the HapMap database for variants with a mi-
nor allele frequency at least 2% using the HapMap tag-SNP picker
option. Several inﬂammatory response SNPs previously associated
with susceptibility or outcome from infection based on literature
review were also included. Genotyping of healthy subjects was
performed using Fluidigm SNPtype assays on a Biomark micro-
ﬂuidics real-time PCR system (Fluidigm, South San Francisco, CA,
USA). rs1927907 was genotyped in patients using primers and
probes designed by RealTimeDesign software from Biosearch
Technologies (https://www.biosearchtech.com) and synthesized by
Biosearch Technologies (Petaluma, CA, USA). The 147 bp region of
TLR4 covering the variant position was ampliﬁed with forward
primer 50-GGTAGACCACCTCTCCCTTTT-30 and reverse primer 50-
GCTGGCCTCTCTGTAAGCA-30. rs1927907 was genotyped using
probes 50-FAM-AGAAGTAGTTTTTCACCAAACA-BHQ-1-30 for allele C
and50 CAL FluorOrange 560-CAAGAAGTAGTTTTTCATCAAAC-BHQ-1
for allele T. Real-time PCR was performed using CFX96 Touch Real-
Time PCR Detection System (Bio-Rad) in a total volume of 20 mL.
Cytokine and chemokine measurements
Cytokine/chemokine assays were performed using Luminex
multiplex bead system with R&D Systems reagents or enzyme-
linked immunosorbent assay (BD; and R&D Systems, Minneap-
olis, MN, USA).
Statistical analyses
Continuous data following a normal distribution are reported as
mean ± standard deviation; continuous data following a non-
normal distribution are reported as median ± interquartile ranges.
Plasma cytokine data were log10 transformed before analysis, given
their generally nonnormal distribution. For the immunoassay data
set, cytokine correlations were assessed using a Pearson correlation
coefﬁcient, and correlation matrices were used to created heat
maps [12] and relatedness dendrograms. To maximize power for
identifying genetic associations, a composite cytokine response
was created. The monocyte-normalized responses for ﬁve cyto-
kines (interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-a,
granulocyte-colony stimulating factor (G-CSF) and IL-1b) were
summed after subtracting the mean and dividing by the standard
deviation of the 300 observations within each cytokine. These cy-
tokines were chosen on the basis of the relatedness score in a
cluster dendrogram. Linear regression of each SNP on composite
cytokine response was performed assuming an additive genetic
model, adjusting for log monocyte count. Eight of the 51 SNPs had
observed minor allele frequencies of <0.05 and were removed from
the primary analysis because of low power in the face of multiple
test adjustment, leaving 43 SNPs for testing with the composite
Fig. 1. SNP in TLR4 is associated with Staphylococcus aureuseinduced cytokine release.
(a) IL-1ra, IL-1b, IL-6, IL-8, IL-10, TNF-a, G-CSF and MCP-1 were measured in plasma
supernatants by multiplex bead assay after stimulation of fresh whole blood from 300
healthy individuals with heat-killed S. aureus 2.5  107 CFU/mL (S. aureus low) or
5  107 CFU/mL (S. aureus high) for 6 hours at 37C. Data are displayed on log scale.
Boxes show median and interquartile range; whiskers show upper and lower adjacent
values; outside values are not shown for clarity. All mediators induced by S. aureus are
signiﬁcantly greater than in unstimulated blood (p <0.001 for all). (b) Cluster
dendrogram created from relatedness scores calculated from pairwise comparisons
between cytokines induced by stimulation of whole blood with S. aureus
2.5  107 CFU/mL used to derive composite outcome measure of TNF-a, IL-6, IL-8, G-
CSF and IL-1b responses. (c) QQ plot (expected vs. observed log10 (1/p values)) for
association of 43 SNPs with composite outcome of S. aureuseinduced cytokine levels
demonstrating several lower-than-expected p values (higher-than-expected log10 (1/p
values)). Lowest p value is rs1927907, intronic SNP in TLR4. G-CSF, granulocyte-colony
stimulating factor; IL, interleukin; MCP, monocyte chemotactic protein; SNP, single
nucleotide polymorphism; TNF, tumor necrosis factor.
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permutation testing [13].
The distribution of the ordered p values under the null hy-
pothesis was produced by permuting the outcomes 2000 times and
recomputing the 43 p values for each permutation. The distribution
of theminimum of the 43 p values for each of the permutationswas
compared with the observed minimum p value to obtain the
probability of observing this minimum under the null hypothesis
(i.e. a multiple-test corrected p value). Corrected p values for the
second and third most signiﬁcant SNPs (and so on) were obtained
analogously. Associations were considered signiﬁcant if the cor-
rected p value was 0.05. Further tests of association of candidate
SNPs with individual cytokines were performed on log10-trans-
formed cytokine data using linear regression, adjusting for log
monocyte count, again assuming an additive genetic model. For
monocyte/monocyte cell line experiments, data were analysed
with the t test. For the clinical study, association of genotype with
cytokine response or clinical outcome was performed with Fisher's
exact test (for clinical outcomes) or with regression, adjusting for
age, sex, comorbidity index and site. The comorbidity index is a 10-
point score, with 1 each given for lung disease, heart disease, kid-
ney disease, liver disease, neurologic disease, haematologic disease,
autoimmune disease, cancer, diabetes and alcoholism. Secondary
analyses were performed adjusting for bacterial species. Analyses
were performed by Stata 11.2 software (StataCorp, College Station,
TX, USA), or R (R Foundation for Statistical Computing, Vienna,
Austria; http://www.r-project.org/).
Ethics
Ethical approval was obtained from the ethics committees of the
following institutions: Faculty of Tropical Medicine, Mahidol Uni-
versity, Bangkok; Sunpasitthiprasong Hospital, Ubon Ratchathani;
Udon Thani Hospital, Udon Thani; Khon Kaen Hospital, Khon Kaen;
and Faculty of Medicine (Srinagarind Hospital), Khon Kaen Uni-
versity, Khon Kaen, Thailand; and the University of Washington,
Seattle.
Results
S. aureus induces robust inﬂammatory responses in blood
To evaluate the inﬂammatory response to S. aureus in human
blood, we assayed pro- and anti-inﬂammatory cytokines and che-
mokines in plasma after stimulation of fresh whole blood from 300
healthy individuals with two different concentrations of heat-killed
S. aureus (Fig. 1A). As expected, S. aureus induced signiﬁcant in-
creases above baseline values for all mediators (IL-1ra, IL-1b, IL-6,
IL-8, IL-10, TNF-a, G-CSF and monocyte chemotactic protein
(MCP)-1), with considerable interindividual variation in responses.
A human TLR4 variant is associated with cytokine responses to
S. aureus
We next analysed the association of candidate PRR pathway ge-
netic variants with cytokine responses induced by S. aureus. We
generated a composite cytokine response by performing pairwise
comparisons between different cytokines produced from whole
blood of each donor after activation with S. aureus and creating a
cluster dendrogram based on intermediator relatedness scores
(Fig. 1B). The most closely related mediators were IL-1b, IL-8, G-CSF,
IL-6 and TNF-a (r ¼ 0.6e0.9). We selected these mediators to use as
the composite measure. We genotyped 96 SNPs in candidate PRR
pathway genes, selected as described in the Methods, in all 300
subjects. Five assays failed and 39 assays had no variation. One assaywas excluded because of a call rate of <97%. The remaining 51 vari-
ants are listed in Supplementary Table S1. Eight variants had
observedminor allele frequencies (MAF) of<0.05 andwere excluded
because of low power. Forty-three variants were tested for an
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variant with the composite S. aureuseinduced cytokine cluster
(Fig. 1C). The top-ranked variant associated with cytokine response
to S. aureuswith p <0.05 (adjusted for multiple comparisons via the
permutation test) and a false discovery rate<0.05was rs1927907, an
intronic TLR4 polymorphism that exchanges a C for a T. The MAF of
rs1927907 in our cohort was 0.10. To determine if a particular cyto-
kine drove the observed composite effect, the association between
rs1927907 and individual cytokine concentrations was tested. We
found that four of the ﬁve cytokines induced by S. aureusdTNF-a, IL-
1b, IL-6 and G-CSFdwere signiﬁcantly higher for carriers of the
rs1927907 minor (T) allele (Table 1). By comparison, rs1927907 was
also associatedwith cytokine responses toE. coli LPS (TNF-a, IL-1b, IL-
6 andG-CSF) andPam3CSK4 (TNF-a and IL-6), but notwith cytokines
induced by Pam2CSK4 or ﬂagellin (data not shown).
rs1927907 is a TLR4 expression quantitative trait locus (eQTL) in
whole blood; the minor allele is associated with increased whole
blood TLR4 expression [14].Moreover, theminoralleleof rs1927907 is
associated with increased TLR4 protein expression on CD4þCD25high
regulatory T cells of asthmatic subjects as determined by ﬂow
cytometry [15]. These data, which are concordant with our observa-
tions of increased blood cytokine responses in carriers of the
rs1927907 minor allele, implicate TLR4 itself in the response to
S. aureus.However, TLR4 is the canonical LPS receptor and therefore is
not anticipated tobe involved in sensingof aGram-positivepathogen.
This prompted us to consider contamination of our S. aureus prepa-
rations with LPS as a potential explanation for these ﬁndings. We
assayed our S. aureus preparations using a sensitive Limulus Amebo-
cyte Lysate assay but did not detect any LPS (data not shown).
S. aureus does not activate TLR4 in vitro
Because we did not ﬁnd any LPS contamination in our prepara-
tions, we postulated that S. aureus might express other factors that
would serve as ligands for TLR4. To address this question, we
stimulated hTLR4/MD-2/CD14-transfected HEK293 cells with our
S. aureus preparations to assess for a TLR4-dependent signal. We
measuredNF-kB activation by luciferase reporter assay but found no
S. aureuseinduced TLR4-dependent light emission (Fig. 2A). This
observation suggested that S. aureus does not express a TLR4 ligand
that signals through NF-kB. We next evaluated how blockade of
TLR4 receptor functionwould affect cytokine responses to S. aureus.
Westimulatedprimarybloodmonocytes fromhealthy subjectswith
S. aureus in the presence of a TLR4/MD-2 neutralizing antibody and
assayed TNF-a concentrations in cell supernatants (Fig. 2B). We
observed no change in TNF-a release when TLR4 receptor function
was impaired. Together, these experiments indicated that S. aureus
does not activate TLR4 to induce inﬂammatory cytokine responses.
Knockdown of TLR4 inhibits the TNF-a response to S. aureus
To explain our observations of differential cytokine response
associated with rs1927907, we next evaluated whetherTable 1
Associations between TLR4 variant rs1927907 and inﬂammatory mediators induced by e
rs1927907 genotype Median (IQR) (pg/mL) for:
IL-6 IL-8
CC 1480 (861e2656) 4532 (3090e7610)
CT 1852 (1304e4117) 5687 (3990e10956)
TT 3096 (701e5492) 7658 (2772e12544)
pa 0.012 0.065
G-CSF, granulocyte-colony stimulating factor; IL, interleukin; IQR, interquartile range; TN
a Linear regression model on log-transformed cytokine concentrations assuming an addifferential expression of TLR4 in the cell may modify the host
response to S. aureus. We surmised that even if S. aureus did not
directly activate TLR4, there may be downstream modulatory
effects of TLR4 on other signaling pathways. We and others have
observed such an effect of TLR5 on TLR4-dependent signaling
(Dickey AK, West TE, paper presented at the 2013 American
Thoracic Society International Conference, abstract A4556; Collin
CJ, Sciurba J, Rice A, Aloor J, Cyphert J, Bulek K, et al., paper
presented at the 2016 American Thoracic Society International
Conference, abstract A2643). We developed an assay using hu-
man monocyte THP-1-Dual cells in which we transfected siRNA
targeting TLR4 or control siRNA (Fig. 2C). We achieved approx-
imately 50% decrease in TLR4 gene expression in this assay. We
next stimulated cells with S. aureus after transfection of siRNA
against TLR4 (Fig. 2D). We measured TNF-a concentration in cell
supernatants and found that levels of this cytokine induced by
S. aureus were signiﬁcantly reduced after TLR4 knockdown.
Collectively, these results supported the concept that S. aureus
does not directly activate TLR4 but that TLR4 modulates the
inﬂammatory response to S. aureus.TLR4 variant rs1927907 is associated with increased cytokine
responses during staphylococcal sepsis
Regulators of the inﬂammatory response to heat-killed S. aureus
in experimental settings may be very different than host response
determinants in clinical staphylococcal infection. To determine
whether rs1927907 might predict cytokine/chemokine responses
in a clinical setting, we genotyped the variant in a cohort of 327
individuals with community-onset staphylococcal sepsis recruited
at four hospitals in northeast Thailand. The clinical characteristics
of these patients are described in Table 2. After ﬁnding no evidence
for deviation from Hardy-Weinberg equilibrium in this cohort (p
0.61), we tested the association of rs1927907 with plasma cytokine
concentration at enrolment. Minor allele homozygotes generated
signiﬁcantly higher levels of IL-6 and IL-8 in crude analyses and
after adjusting for age, sex, comorbidity index and site (adjusted p
0.01 and 0.045, respectively) (Fig. 3).TLR4 variant rs1927907 is associated with increased respiratory
failure during staphylococcal sepsis
We then tested whether rs1927907 genotype predicted clinical
outcome from staphylococcal sepsis. In both crude and adjusted
analyses, minor allele homozygotes developed signiﬁcantly more
respiratory failure (adjusted odds ratio 9.65, 95% conﬁdence in-
terval 1.60e58.08, p 0.01) (Table 3). These individuals did not have
signiﬁcantly greater rates of shock or death, outcomes that were
less frequent overall. Together, these cytokine and clinical data in
an independent cohort of patients offer conﬁrmatory evidence in
support of the role of TLR4 as a modulator of the host response in
staphylococcal sepsis.x vivo stimulation of blood from 300 healthy subjects with Staphylococcus aureus
TNF-a IL-1b G-CSF
927 (574e1433) 763 (463e1328) 55 (34e99)
1128 (726e2684) 1100 (699e1727) 82 (49e148)
1833 (219e3447) 2243 (599e3886) 99 (27e170)
0.017 0.002 0.001
F, tumor necrosis factor.
ditive genetic model and adjusting for monocyte count.
Fig. 2. Staphylococcus aureus does not activate NF-kB or induce TNF-a release via TLR4 ligation but TLR4 modulates S. aureuseinduced TNF-a release. (a) HEK293 cells were
transiently transfected with hTLR4 or equivalent amounts of empty vector, hMD-2, hCD14, ELAM (ﬁreﬂy luciferase) and pRL-TK (Renilla luciferase) before stimulation for 4 hours with
Escherichia coli LPS or heat-killed S. aureus. NF-kB activation was determined in cell lysates by ratio of ﬁreﬂy to Renilla luciferase light emission. Mean ± standard deviation values of
quadruplicate samples are displayed. ***p <0.001 compared to unstimulated TLR4-transfected cells. (b) Primary blood monocytes from four healthy individuals were treated with
monoclonal TLR4/MD2 neutralizing antibody or control isotype antibody at 20 mg/mL, 1 hour before stimulation for 6 hours with LPS from Burkholderia pseudomallei K92643 1 ng/
mL or heat-killed S. aureus at bacteria-to-cell ratio of 100. TNF-a was assayed by ELISA in supernatants. Individual data (each with unique symbol) representing means of duplicate
or triplicate samples normalized to LPS-induced TNF-a release are displayed. ***p <0.001. (c) THP-1-Dual cells were transfected with siRNA against TLR4 or negative control siRNA at
5 nM. After 48 hours, TLR4 gene expression was determined by quantitative real-time PCR. TLR4 gene expression is presented relative to housekeeping gene UBC expression and
normalized to control siRNA transfection results. Mean ± standard deviation values of quadruplicate samples from two independent experiments are displayed. *p <0.05. (d) THP-1-
Dual cells transfected for 48 hours as in (c) were stimulated with B. pseudomallei LPS 100 ng/mL or heat-killed S. aureus at bacteria-to-cell ratio of 100 overnight. TNF-a was assayed
by ELISA in supernatants. Mean ± standard deviation values of quadruplicate samples normalized to LPS-induced TNF-a release are displayed. Data comprise one representative
example of three independent experiments. *p <0.05; ***p <0.001. ELISA, enzyme-linked immunosorbent assay; LPS, lipopolysaccharide; TNF, tumor necrosis factor.
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and B. pseudomallei
In light of our data implicating TLR4 in the immune response to
S. aureus, we then sought to determine whether inﬂammatory
responses induced by S. aureus in healthy individuals might be
correlated with responses induced by LPS or by Gram-negative
bacteria in our human blood immunoassay. We selected E. coli
LPS, S. minnesota LPS and heat-killed B. pseudomallei for this
comparison. As control stimulants, we chose TLR2/6 agonist
Pam2CSK4, TLR2/1 agonist Pam3CSK4, TLR5 agonist
S. typhimurium ﬂagellin, NOD1 agonist Tri-DAP and NOD2 agonist
MDP. We measured the correlations between each stimulus andcreated heat maps with derived relatedness dendrograms. Across
all cytokines, the dendrograms indicated highest relatedness be-
tween responses to S. aureus and LPS or between S. aureus and
B. pseudomallei. For example, the correlation between TNF-a
induced by S. aureus and by S. minnesota LPS was 0.61 (p <0.0001),
and the correlation between IL-8 induced by S. aureus and by
B. pseudomallei was 0.67 (p <0.0001) (Fig. 4).
Discussion
The main ﬁndings of this study are as follows: blood inﬂam-
matory responses to S. aureus are associated with the TLR4 genetic
polymorphism rs1927907, an eQTL, both ex vivo and in patients
Table 2
Clinical characteristics and outcomes of 327 patients with staphylococcal
sepsis
Variable Value
Age, years, median (IQR) 54 (42e65)
Female sex, n (%) 114 (34.9)
Preexisting conditions, n (%)
Diabetes mellitus 116 (35.5)
Heart disease 17 (5.2)
Kidney disease 53 (16.2)
Liver disease 13 (4.0)
Lung disease 18 (5.5)
Cancer 7 (2.1)
Alcoholism 5 (1.5)
Autoimmune disease 5 (1.5)
Neurologic disease 8 (2.5)
Haematologic disease 9 (2.8)
Comorbidity index, median (IQR)a 1 (0e1)
Outcome, n (%)
Respiratory failure 58 (17.7)
Shock 38 (11.6)
Death at 28 days 30 (9.2)
a Comorbidity index is a 10-point score with 1 point each given for lung
disease, heart disease, kidney disease, liver disease, neurologic disease, hae-
matologic disease, autoimmune disease, cancer, diabetes and alcoholism.
Fig. 3. TLR4 variant rs1927907 is associated with plasma IL-6 and IL-8 in patients with stap
patients with staphylococcal sepsis and are displayed by TLR4 variant rs1927907 genotype.
values; outside values are not shown for clarity. Values were log10 transformed, and linear
subjects), adjusting for age, sex, comorbidity index and site. n ¼ 249 (CC), 69 (CT), 6 (TT). *
Table 3
Association of TLR4 variant rs1927907 with clinical outcomes of patients with staphyloc
Genotype Respiratory failure S
Yes No Y
CC 42 (72%) 210 (78%) 2
CT 12 (21%) 57 (21%) 7
TT 4 (7%) 2 (1%) 2
Unadjusted pa 0.018 0
Adjusted OR (95% CI) 9.65 (1.60e58.08) 4
Adjusted pb 0.01 0
CI, conﬁdence interval; OR, odds ratio.
a Unadjusted analyses performed by exact test.
b Adjusted analyses performed by logistic regression assuming recessive genetic mod
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TLR4 knockdown impairs TNF-a release induced by S. aureus;
rs1927907 predicts respiratory failure in patients with staphylo-
coccal sepsis; and blood inﬂammatory responses to S. aureus are
tightly correlated with responses to LPS and a Gram-negative or-
ganism. These ﬁndings raise intriguing new questions about the
role of TLR4 in human staphylococcal sepsis.
TLR4 is not usually considered a fundamental participant in the
host response to Gram-positive infections. The S. aureus cell wall
is composed of peptidoglycan in combination with other sub-
stances such as lipoteichoic acid (LTA) and lipoprotein. These
components and secreted proteins can induce inﬂammation and
may contribute to sepsis [4]. PRRs on host immune cells involved
in recognition of S. aureus include TLR2 in combination with TLR1
or TLR6 and/or CD36 and CD14 [4]. While the cell wall of Gram-
negative bacteria shares many of the same PAMPs as Gram-
positive bacteria [3], a cell wall component unique to Gram-
negative organisms is LPS [5]. LPS is known as a TLR4 agonist
and induces a robust proinﬂammatory response and septic shock
[16], but it is not expressed by S. aureus. Therefore, whenwe found
associations between inﬂammatory responses and genetic varia-
tion in TLR4 and observed tight correlation between responses tohylococcal sepsis. IL-6 (a) and IL-8 (b) were assayed by ELISA in plasma samples from
Boxes show median and interquartile range; whiskers show upper and lower adjacent
regression was performed using recessive model (comparing CC and CT subjects to TT
*p 0.01; *p <0.05. ELISA, enzyme-linked immunosorbent assay; IL, interleukin.
occal sepsis
hock Death
es No Yes No
9 (76%) 223 (77%) 22 (73%) 230 (77%)
(18%) 62 (21%) 7 (23%) 62 (21%)
(5%) 4 (1%) 1 (3%) 5 (2%)
.22 0.51
.31 (0.66e27.96) 1.75 (0.18e17.11)
.13 0.63
el adjusting for age, sex, comorbidity index and site.
Fig. 4. High correlation between blood inﬂammatory responses induced by Staphylococcus aureus and LPS or Burkholderia pseudomallei. Heat maps of correlation between TNF-a (a)
or IL-8 (b) responses induced by stimulation of whole blood from 300 healthy subjects with panel of puriﬁed innate immune ligands and heat-killed bacteria for 6 hours at 37C.
Stimulants were heat-killed S. aureus 2.5  107 CFU/mL (SAlow) and 5.0  107 CFU/mL (SAhigh), heat-killed B. pseudomallei 2.5  107 CFU/mL (BP), Salmonella typhimurium ﬂagellin
500 ng/mL (Flg), Pam3CSK4 100 ng/mL (Pam3), Pam2CSK4 100 ng/mL (Pam2), Escherichia coli O111:B4 LPS 10 ng/mL (EClps) and Salmonella minnesota Re595 LPS 10 ng/mL (SMlps).
Dendrogram of hierarchical clustering results for correlation matrix for each mediator is shown. Lowest correlation is red (Pearson correlation coefﬁcient r < 0.1) and highest
correlation is white (r ¼ 1.0). Scatter plots of individual TNF-a (c) or IL-8 (d) responses (log10 transformed) after stimulation of fresh whole blood from 300 healthy subjects with
heat-killed S. aureus 5  107 CFU/mL, S. minnesota Re595 LPS (C) or heat-killed B. pseudomallei 2.5  107 CFU/mL (d) for 6 hours at 37C. For each plot, relationship between variables
as determined by linear regression (dotted line) and Pearson correlation (correlation coefﬁcient, r) are shown. IL, interleukin; LPS, lipopolysaccharide; TNF, tumor necrosis factor.
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nation in our experiments. We also considered that activation of
TLR4 may occur by bacterial ligands other than LPS [17]. For
example, the S. aureus exotoxin leukocidin has been reported to
induce TLR4-dependent immune responses [18]. Yet we did not
ﬁnd that TLR4 was activated by our preparations of S. aureus, at
least via the transcription factor NF-kB.
Two other explanations may account for our ﬁndings. First,
TLR4 may respond to endogenous ligands produced by the host
[19]; during infection, this effect may be sufﬁciently strong to
result in altered TLR4-dependent inﬂammatory responses and
clinical outcomes. This is supported by a report that haemoglobin,
a host blood product, can signiﬁcantly enhance macrophage
secretion and expression of several cytokines and receptors in a
TLR4-dependent pathway when activated with low levels of TLR2
ligands such as LTA and Pam3CSK4. Haemoglobin can also lead tosecretion of high mobility group box 1 protein (HMGB1), which
synergizes with LTA to increase secretion of IL-6 [20]. Second, TLR4
may contribute to the inﬂammatory response without direct
ligation of the receptor. This seems like the most likely explana-
tion for our observations, as cytokine release in monocytes was
not impaired by antibody-mediated blockade of TLR4, yet cyto-
kine release in a monocyte cell line was blunted after transfection
of siRNA reducing TLR4 gene expression. Cooperative behavior by
TLRs may alter inﬂammatory responses even when the ligand is
speciﬁc for only one of the interacting TLRs. For example, we and
others have found that TLR5 may alter TLR4-dependent signaling
(Dickey AK, West TE, paper presented at American Thoracic So-
ciety International Conference, 2013, abstract A4556; Collin CJ,
Sciurba J, Rice A, Aloor J, Cyphert J, Bulek K, et al., paper presented
at American Thoracic Society International Conference, 2016, ab-
stract A2643). Furthermore, recent work suggests that TLR4
N. Chantratita et al. / Clinical Microbiology and Infection 23 (2017) 47.e1e47.e10 47.e9contributes to murine macrophage responses to S. aureus and that
TLR2 and TLR4may interact in this process [21]. Thus, althoughwe
present data that implicate TLR4 as a modulator of the host
response to S. aureus, the mechanism by which this may occur
requires further elucidation.
Genetic variation in innate immunity is well established as a
modulator of inﬂammatory responses and outcome in sepsis
[22e24]. Our focus on Thai subjects offers important new data as
population differences in genetic association studies of sepsis are
critical to consider. For example, functional TLR1 variants are
associated with outcomes from sepsis in white North American
subjects [22], but we have shown that TLR1 genetic architecture is
profoundly different and variants are nonfunctional in Southeast
Asians [25]. rs1927907 is an intronic variant in TLR4 that is common
throughout the world (MAF 0.11e0.25 [26]). Notably, the clinical
associations reported to date are restricted to Chinese populations;
the variant is associated with late-onset Alzheimer disease [27],
asthma severity [15,28] and tacrolimus pharmacokinetics after liver
transplantation [29], neonatal early Crohn disease [30] and chronic
periodontitis in a TLR4 haplotype [31]. In the Southern Han Chinese
population, the variant is in high linkage disequilibrium (r2 ¼ 0.87)
with a TLR4 promoter region variant, rs10983755 [26]. Ragnars-
dottir et al. have reported that rs10983755 disrupts a potential
binding site for the transcription factor N-Myc and increases pro-
moter activity in HEK293 cells on infection with E. coli [32].
Moreover, rs1927907 is in high linkage disequilibrium with
rs960312, a TLR4 polymorphism that we have found to be associ-
ated with susceptibility to melioidosis, a common Gram-negative
infection in northeast Thailand [33]. Thus, the haplotype tagged
by rs1927907 is of considerable interest.
Several lines of evidence link rs1927907 to altered TLR4
expression at both the gene and protein level. In a study of over
5300 whole blood specimens, rs1927907 was identiﬁed as a TLR4
eQTL, with increasing TLR4 gene expression observed in carriers of
the minor allele [14]. Moreover, the minor allele of rs1927907 is
associated with increased TLR4 protein expression on
CD4þCD25high regulatory T cells of asthmatic subjects as deter-
mined by ﬂow cytometry [15]. While not excluding trans (more
distant) effects of rs1927907 on expression of other genes, these
ﬁndings complement our ﬁndings of increased cytokine responses
in carriers of the rs1927907 minor allele and more concretely
implicate TLR4 in this process. Further work is required to more
completely understand the variation driving the observed associ-
ations and to replicate the clinical associations in other populations.
In light of the overlapping but not identical pathways activated
by Gram-positive and Gram-negative bacteria, whether and how
Gram-positive sepsis differs from Gram-negative sepsis is debated
[34,35]. In comparison to other PAMPs, we found that responses to
LPS and to B. pseudomallei were most highly correlated with
S. aureuseinduced responses. This suggests a shared common
pathway of inﬂammation precipitated by Gram-positive and Gram-
negative bacteria. A study by Tang et al. showed that the human
sepsis transcriptome in Gram-positive sepsis is similar to the
transcriptome in Gram-negative sepsis [36]. While this report also
supports a common host response in the pathophysiology of sepsis
regardless of infecting organism, a potentially confounding factor in
clinical or in vivo studies is that LPS derived from gut bacteria may
be released systemically during bowel hypoperfusion from sepsis of
any etiology [37]. Our ex vivo data, obtained under controlled
experimental conditions, avoid confounding by gut bacteria LPS
release and provide corroborating protein-level evidence of shared
pathway activation.
Several important limitations to our study deserve mention.
First, the use of killed bacteria may not mimic the innate immune
responses induced by live pathogens. Second, our analysis isrestricted to the optimal concentrations of speciﬁc PAMPs chosen
that induced detectable cytokine responses; conceivably there may
be additional dose-dependent effects that have not been identiﬁed.
Third, our genetic analyses may be confounded by population
stratiﬁcation and may potentially differ in non-Thai subjects.
Fourth, although we reported signiﬁcant associations of rs1927907
with respiratory failure or plasma cytokines, the number of subjects
with the recessive genotype in our clinical study was low, and our
results may be biased by unmeasured confounding. While the as-
sociation of rs1927907 with cytokine responses in whole blood
stimulation ex vivo was determined using an additive genetic
model, the associations in the clinical study were apparent using a
recessive genetic model. This may be due to inadequate power to
distinguish between the relative contributions of these models in
human infection, or it may reﬂect different biological effects ex vivo
versus in infected humans. Independent replication of these results
in larger clinical cohorts is therefore important. Fifth, our study was
likely underpowered to detect associations with shock or death, but
we note that IL-6 and IL-8 levels strongly predict these outcomes in
our cohort. Finally, the proinﬂammatory cytokines investigated in
our study are mainly driven by shared NF-kB/MAP kinaseesignal-
ing pathways downstream of the PRRs. We did not investigate
interferon production, such as that mediated by interferon regu-
latory factors (IRFs). It has been recently reported that S. aureus RNA
activates IRF5 via TLR8 and that this is antagonized by TLR2 acti-
vation [38]. How this sensing pathway relates to our ﬁndings ne-
cessitates further investigation.
Strengths of our immunoassay study include the prospective
nature of healthy subject recruitment from a blood donor pool, the
large number of subjects assayed and highly standardized blood
processing techniques, as well as batched generation of assays,
measurement of cytokines and genotyping. Furthermore, we
replicated and extended our initial genetic associations in patients
from the same region recruited in a prospective multisite study of
staphylococcal sepsis. To our knowledge, our study is one of the
ﬁrst to identify innate immune genetic variants that predict out-
comes from Gram-positive sepsis in Asians.
In conclusion, in Thais, a genetic variant in TLR4 that is an eQTL is
associated with whole blood cytokine responses to S. aureus ex vivo
and with plasma cytokine levels and respiratory failure in staphy-
lococcal sepsis. While S. aureus does not express LPSdthe canonical
TLR4 liganddor activate TLR4 directly, the innate immune response
to S. aureus does appear to be modulated by TLR4 and shares sig-
niﬁcant commonality with that induced by Gram-negative patho-
gens and LPS. These data suggest a regulatory role for TLR4 beyond
canonical LPS-receptor ligation in Gram-positive sepsis.
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